Kopin I J, Zukowska-Grojec Z, Bayorh M A, Goldstein D S
Naunyn Schmiedebergs Arch Pharmacol. 1984 Apr;325(4):298-305. doi: 10.1007/BF00504372.
We estimated vascular neuroeffector junctional norepinephrine concentrations and their relation to pressor responses by measuring plasma norepinephrine levels and blood pressure during sympathetic stimulation or norepinephrine infusion in pithed, vagotomized, alpha 2-adrenoceptor blocked, adrenal-demedullated rats with and without uptake1 blockade by desipramine. For an increment in mean arterial pressure of 50 mm Hg, the estimated mean junctional norepinephrine concentration ( ES50m ) was about 7 nmol/l. Norepinephrine concentration gradients between the site of norepinephrine release and plasma appeared to be equal and reciprocal for sympathetic stimulation and for norepinephrine infusion. These gradients were reduced equally (by about two-thirds) after desipramine treatment, indicating that removal of both released and infused norepinephrine is mainly by neuronal uptake.
我们通过在经脊髓横断、迷走神经切断、α2-肾上腺素能受体阻断、肾上腺髓质切除的大鼠中,在有或没有地昔帕明摄取1阻断的情况下,测量交感神经刺激或去甲肾上腺素输注期间的血浆去甲肾上腺素水平和血压,来估计血管神经效应器接头处的去甲肾上腺素浓度及其与升压反应的关系。对于平均动脉压升高50 mmHg,估计的平均接头去甲肾上腺素浓度(ES50m)约为7 nmol/L。交感神经刺激和去甲肾上腺素输注时,去甲肾上腺素释放部位与血浆之间的去甲肾上腺素浓度梯度似乎相等且呈反比。地昔帕明治疗后,这些梯度同等程度降低(约降低三分之二),表明释放的和输注的去甲肾上腺素的清除主要通过神经元摄取。